FDA approves RSV vaccine to protect babies from birth
Drug Discovery World
AUGUST 23, 2023
The US Food and Drug Administration (FDA) has approved the first vaccine for pregnant individuals to prevent respiratory syncytial virus (RSV) in infants. The FDA approved Abrysvo in May for the prevention of LRTD caused by RSV in individuals 60 years of age and older.
Let's personalize your content